Ray Therapeutics
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust69Data Trust: 69/100. Above median. Measured by StartupHub.ai. Median 61.Pioneering vision restoration therapies for severe retinal degenerations.
About
Ray Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies to restore vision for individuals suffering from severe retinal degenerations. Their approach aims to address unmet medical needs in ophthalmology.
Listed competitors
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Life Sciences
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- raytherapeutics.com
- Headquarters
- Berkeley, California, USA
- Founded
- 2021
- Total funding
- $243M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Apr 2026 | Series B | $125M | Janus Henderson Investors |
| 24 Apr 2025 | Grant | $8M | |
| 16 May 2023 | Series A | $100M | Novo Holdings |
| 26 Apr 2022 | Grant | $4M | |
| 4 Jan 2022 | Seed Round | $6M |
Tech stack
Detected on raytherapeutics.com, last scanned 20 Oct 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Barracuda
Ray Therapeutics scores 32. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Ray Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Ray Therapeutics is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Ray Therapeutics raised?
Ray Therapeutics has raised a total of $243M in funding. The most recent round on record is Series B.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Ray Therapeutics
